drugset / Trial / NCT05529173

Povidone-Iodine for Nasal Decolonization

NCT05529173

Phase 4 Completed 192 enrolled Rutgers, The State University of New Jersey
RandomizedParallel-groupSingle-blindPrevention

Summary

To evaluate the efficacy and tolerability of 10% povidone-iodine in eliminating nasal carriage of Staphylococcus aureus and MRSA. To determine whether a more convenient, single-dose, pre-operative 10% povidone-iodine (PI) application is effective in reducing nasal carriage of S. aureus and MRSA. We expect a statistically significant decrease in S. aureus/MRSA colonization in nasal cultures taken perioperatively after intervention in patients who received pretreatment with PI as compared to patients who received normal saline (NS).

Timeline

Start
2022-09-06
Primary completion
2023-11-13
Completion
2023-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 10 % Intranasal